written on 26.06.2014
Tags:
,

UPDATED: Ranbaxy's generic of Novartis blockbuster Diovan approved for launch

TAGS: ,

The long-delayed and highly anticipated launch of generic Diovan is on the way, which is a bummer for Novartis and a huge boost for Indian drugmaker Ranbaxy Laboratories. It is also validation for the decision by Sun Pharmaceutical's owner, billionaire Dilip Shanghvi, who struck a $3.2 billion deal to buy Ranbaxy despite its years of FDA entanglements over quality issues.

Latest Report